A comparision of combination antiemetic regimens for prevention of PONV in breast surgery patients
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: MEYER, Patricia (Scott and White, Department of Pharmacy, Temple, United States of America)
- Co-author(s): McAllister, R. (Scott and White, Temple, United States of America)
Roberson, C. (Scott and White, Temple, United States of America)
Song, J. (Scott and White, Temple, United States of America)
Postoperative nausea and vomiting (PONV) is one of the most common complications after surgery with a 68% incidence in breast surgery patients.
After IRB approval, the prospective, randomized, double-blind, placebo-controlled pilot study was conducted in breast surgery females. Subjects were assigned to: Group I, aprepitant 40 mg, ondansetron 4 The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.